ANMA Home

Code of Ethics

Top Stories
  Naturopathic Legislative Alert!    NEW!
  Florida Sunrise Report
   CA Legislation 
   Arizona's Opinion
   Nat. Scandal in AZ
   Nat. School Under Fire
   CNME, "otherwise not
   approved accred. agency"
   History & Demise of CNME
   AANP vs. Hayhurst & ANMA
         AANP Loses Again

27th Annual Convention (7/25/08)        Convention Lecture
    & Workshop Schedule
   Convention Registration Form

E-mail

ANMA ONLINE REFERENCES

Volume 9  Number 1

DHA and Your Health

By: Wendy Arthur, M.D.

i Gibson RA, Neumann MA, Makrides M. Effect of dietary docosahexaenoic acid on brain composition and neural function in term infants. Lipids 1996;31:177S-81S.

ii Alberts et al. Molecular Biology of the Cell, Garland Publishing, N.Y., 1994, Third Edition,

iii Crawford MA, Costeloe K, ET al. Are deficits of arachidonic and docosahexaenoic acids for the neural and vascular complications of preterm babies? AM J Clin Nutr 1997;66(suppl):1032S-41S.

ivSanjurjo P, Ruiz-Sanz JI, et al. Supplementation with docosahexaenoic acid in the last trimester of pregnancy: maternal-fetal biochemical findings.Unit of Infant Metabolism, Department of Pediatrics, Hospital de Cruces, Baracaldo, Spain. psanjurjo@hcru.osakidetza.net

v Stoll AL, Sverus WE, Freeman MP, et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo controlled trial.

vi No author. Omega-3 fatty acids in bipolar disorder. Ongoing clinical trial sponsored by NCCAM.

vii Young GS, Maharaj NJ, Conquer JA. Blood phospholipid fatty acid analysis of adults with and with out attention deficit/hyperactivity disorder. Lipids. 2004 Feb;39(2):117-23.

viii Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, Prescott SL. Allergies Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: A randomized, controlled trial. Pubmed in process. Accessed 5/12/04.

ix Theobald HE, Chowienczyk PJ, et al. AM J Clin Nutr. 2004 Apr; 79(4):558-63.

x Stark KD, Holub BJ. Am J Clin Nutr. 2004 May; 70(5):765-73.

xi Frasure-Smith N, Lesperance F, Julien P. Major Depression is associated with lower omega-3 fatty acid levels in patients with recent coronary syndromes. Biol Psychiatry. 2004 May 1; 55(9):891-6.

xii Payet M, Esmail MH, et al. Docosahexaenoic acid-enriched egg consumption induces accretion of arachidonic acid in erythrocytes of elderly patients. Br J Nutr. 2004 May;91(5):789-96.

xiii Nichols P, Mooney B, Elliot N. Is farmed Australian seafood a better source of the good oil thn wild-caught seafood? Asia Pac J Clin Nutr. 2003;12 Suppl:S34

By: Paul Yanick, Jr., Ph.D., ND, CNC, CQM

1. Yanick P MCS: Understanding Causative Factors. Townsend Letter for Doctors. 2001 (Jan) 55-59.

2. Yanick P New Perspectives on Allergies and Seasonal Disorders. May 2001, Townsend Letter for Doctors and Patients, 45-8.

3. Yanick P. Lymphatic Therapy for Chronic Immune & Metabolic Disorders, Detoxification. Townsend Letter for Doctors, January 1995, 34-40.

4. Yanick P. New Insights into Brain Fog, Memory & Learning Disorders, Insomnia, Anxiety, Depression and Immune Disorders. Townsend Letter for Doctors & Patients, June, 2000, 154-56.

5. Yanick P. Hormone Resistance and the Ground Regulation System. Townsend Letter for Doctors & Patients, January 1999, 88-90.

6. Yanick P Detoxification Breakthroughs for Addictions and Chronic Toxicity. Townsend Letter for Doctors and Patients. 2001 (July) 93-95.

7. Yanick P Oral Chelation of Biliary Tract and Circulatory System. Townsend Letter for Doctors and Patients. 2002 (Nov) 52-55.

8. Yanick P Disorders of the gall bladder-duodenum in overweight patients. June 1994. Townsend Letter for Doctors and Patients. 568-70.

9. Yanick P Mycotoxicosis: A new emerging cofactor in Alzheimer's, Environmental Illness .. July 2002. Townsend Letter for Doctors and Patients 154-8.

10. Yanick P Histadine-GLA-Zinc Complex to Block Unwanted Pain & Inflammation. Townsend Letter for Doctors and Patients. 2004 (Feb-March) 164-167.

11. Ashford NA, Miller CS. Chemical Exposures: Low Levels and High Stakes. 2nd Edn, New York, NY; Van Nostrand Reinhold, 1998.

12. Cullen M. The Worker with MCS: an overview. In Cullen M (ed.) Occupational Medicine: State of the Art Review. Ohil Handley and Belfusi 1987:2; 655-63.

13. Gail McKeown-Eyssen et al: Case-control study of genotypes in multiple chemical sensitivity: International Journal of Epidemiology, 2004;33:1-8.

14. Haley RW et al: Association of low PQNI aleresterase activity with neurological symptoms in Gulf War veterans. Toxicol Appl Pharmacol 1299; 157:227-33.

15. Binkley K et al: Idiopathic Environmental Intolerance… J Allergy Clin Immunol 2001;107: 887-90.

16. Orth DN, et al: The adrenal cortex. In: Wilson JD, Foster DW (eds) 1992 William's Textbook of Endocrinology. Saunders, Philadelphia, pp 489-619.

17. Miller WL 1988 Molecular biology of steroid hormone synthesis. Endocr Rev 9:295-318.

18. Engeland WC, et al: Expression of cytochrome P450 aldosterone synthase, 11ß-hydroxylase mRNA during adrenal regeneration.1995 Endocr Res 21:449-454.

19. Lehoux J-G, Mason JI, Ducharme L 1992 In vivo effects of ACTH on hamster steroidogenic enzymes. Endocrinology 131:1874-1882.

20. Hanukoglu I. Steroidogenic enzymes: structure, function: Rrole in regulation of steroid hormone biosynthesis. J. Steroid Biochem. Mol. Biol. 43:779-804, 1992.

21. Seem M: Acupuncture Imaging. Healing Arts Press, 1990, Vermont.

22. Yanick, P Quantum Medicine, Writer Service Publications, Portland, Oregon, 2000.

23. Yanick, P. Boosting Nutrient Uptake in Chronic Illness, Townsend Letter for Doctors & Patients, December 2000.

24. Yanick P. Meridian/Organ Nutraceutic Resonant Complexes. Townsend Letter for Doctors & Patients, May, 2000, 136-39.

25. McTaggert L: The Field. Harper Collins, 2001, Hammersmoth, London.

26. Yanick P The Quantum Naturopath: Activating Quantum Healing with New Flexoelectric Technology. Feb/March 2003. Townsend Letter for Doctors and Patients. 154-56.

27. Yanick P Quantum Repatterning Technique Amer Chiropractic 2003; 50.

28. Yanick P The Quantum Repatterning Technique: Assessing Immunological Unresponsiveness in Prolonged Viral Illness. Townsend Letter for Doctors and Patients. 2003 (Jan) 128-130.

29. Asano, K. et al. Effect of Eleutherococcus senticosus extract on human physical working capacity. 1986, Planta Med 3:175-177.

30. Bohn, B. et al: Flow-cytometric studies with E. senticoccus extract as an immunomodulatory agent. 1987, Arzneimforsch 37(10):1193-1196.

31. Bradley, P.R. (ed.). British Herbal Compendium, 1992 . 1. Bournemouth: British Herbal Medicine Association.

32. Bruneton, J. Pharmacognosy, Phytochemistry, Medicinal Plants. 1995,Paris: Lavoisier Publishing.

33. Dowling EA et al. Effect of Eleutherococcus senticosus 1996. Med Sci Sports Exerc 28(4):482-499.

34. Fang J et al. Immunologically active polysaccharides of E. senticosus. 1985 Phytochem 24:2619-2622.

35. Tang, W. and G. Eisenbrand. Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional & Modern Medicine. 1992. NY: Springer Verlag.

36. Wagner H H.et al: Economic and Medicinal Plant Research. 1985, London; Orlando, FL: Academic Press. 155-215.

37. See, D. Journal of the American Nutraceutical Association, 1996, Vol 2:1, 25-41.

38. Rea, WJ Chemical Sensitivity 1992 Lewis Publishers, Florida.

39. Low R Secondary Vessels of Acupuncture 1985. London, UK: Thorson's Publishers.

40. Van Nghi N & Chamfrault, A L'Energetique Humaine 1969 Angouleme, France Charente Printers.

41. Emery, p et al Ann Rheum Dis, 1992 51:3, 318-20.

42. Gordon C et al Lancet, 1992, 339:8784, 25-6.

43. Tanner CM Neurology, 1991, 41:5 Suppl 2, 89-91.

44. Steventon G et al. Xenobiotic metabolism in motor neuron disease. Lancet 1988;2(8612):644-7.

45. McFadden SA. Phenotypic variation in xenobiotic metabolism and adverse environmental response: focus on sulfur-dependent detoxification pathways. Toxicology 1996;111(1-3):43-65.

46. Tanner CM. Liver enzyme abnormalities in Parkinson's disease. Geriatrics 1991;46(Suppl 1):60-63.

47. Steventon GB et al. Xenobiotic Metabolism in Alzheimer's Disease, NEUROLOGY,1989: 40:1095-98

48. Steventon GB et al. A review of xenobiotic metabolising enzymes in Parkinson's disease and motor neuron disease, Drug Metabolism and Drug Interactions, 2001 18, 79-98.

49. Millard J et al Expression of CDO and sulfite oxidase in the human lung: a potential role for sulfate in the protection from airborne xenobiotica. Molecular Pathology 2003; 56:270-74.

50. Stanley LA et al. Cytochrome P-450 induction in human lung tumor-derived cell lines. Characterization and effects of inflammatory mediators. Eur J Biochem 1992; 208:521-9.

51. Hume R et al. Differential expression and immunohistochemical localization of the phenol and hydroxysteroid sulphotransferase enzyme families in the developing lung. Histochem Cell Biol 1996;105:147-52.

52. Florin T et al. Metabolism of dietary sulphate: absorption and excretion in humans. Gut 1991;32:766-73.